BioVie, Inc. (BIVI)
1.525
-0.04
(-2.24%)
USD |
NASDAQ |
Apr 20, 12:56
BioVie SG&A Expense (Quarterly) : 1.936M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Lantern Pharma, Inc. | 1.458M |
| ACADIA Pharmaceuticals, Inc. | 155.62M |
| Alnylam Pharmaceuticals, Inc. | 325.37M |
| Savara, Inc. | 12.53M |
| BioMarin Pharmaceutical, Inc. | 446.21M |